Tag Archive | "Endo"

Endo International acquires Par Pharmaceutical

Tags: , ,


Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Read the full story

M&A news: Auxilium Pharmaceutical joins Endo, rejects QLT

Tags: , , ,


In today's m&a news, Auxilium Pharmaceutical has agreed to be acquired by Endo International for $2.6 billion, causing it to reject its previously announced merger agreement with QLT for $345 million.

Read the full story

Auxilium rejects M&A bid by Endo for $2.2 billion

Tags: , , ,


M&A news: Endo International has offered $2.2 billion to acquire Canada-based, Auxilium. Read the full story

Endo enters into a m&a with DAVA Pharma

Tags: , , ,


Endo International to acquire DAVA Pharmaceuticals for $575 million in cash, with additional cash consideration of up to $25 million contingent on the achievement of certain sales milestones. Read the full story

Endo have acquired the right to Sumavel DosePro from Zogenix

Tags: , , ,


Endo International have acquired worldwide rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use, a needle-free delivery system for sumatriptan, from Zogenix. Read the full story

M&A News: Endo Health disposes of HealthTronics for $130 million

Tags: , ,


In m&a news, Endo Health Solutions has completed the divestiture of HealthTronics to Altaris Capital Partners. Read the full story

Endo Health enters into a m&a deal for $105 million

Tags: , ,


Endo Health Solutions has entered into a definitive agreement for a m&a deal to acquire NuPathe. Read the full story

Endo Pharmaceuticals: Partnering activity 2005-2013

Tags: , ,


Endo Health Solutions, a company focused on healthcare solutions operate through it's companies AMS, Endo Pharmaceuticals, HealthTronics and Qualitest. Read the full story

Endo Pharmaceuticals: Blending internal R&D, licensing and M&A’s

Tags: , ,


Endo Pharmaceuticals is a top 50 pharma company specialising in brand pharmaceuticals for the treatment of pain, urology, oncology, CNS and derma products. Read the full story

Acquisition agreement between Endo and Paladin Labs for $1.6 billion

Tags: , , , ,


Endo Pharmaceuticals enters into a acquisition agreement with Canadian  based Paladin Labs Read the full story